Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling.
复制标题
DOI:
10.1038/onc.2009.203
复制
发表时间:
2009-09-24
期刊:
影响因子:
8
通讯作者:
Trackman, P. C.
中科院分区:
文献类型:
--
作者:
Palamakumbura, A. H.;Vora, S. R.;Nugent, M. A.;Kirsch, K. H.;Sonenshein, G. E.;Trackman, P. C.
Enhanced RAS signaling and decreased androgen dependence of prostate cancer cells accompany poor clinical outcomes. Elevated autocrine FGF-2 signaling promotes prostate cancer cell growth and survival. Expression of lysyl oxidase (LOX) inhibits RAS transforming activity. LOX is secreted as 50 kDa pro-lysyl oxidase protein and then undergoes extracellular proteolytic processing to form ~30 kDa lysyl oxidase enzyme and ~18 kDa pro-peptide (LOX-PP). We have previously shown that LOX-PP inhibits breast cancer cell transformation and tumor formation, but mechanisms of action of LOX-PP have not been fully elucidated. Here we report that LOX expression is reduced in prostate cancer cell lines and that recombinant LOX-PP protein inhibits serum-stimulated DNA synthesis and MEK/ERK and PI3K/AKT pathways in DU 145 and PC-3 androgen-independent cell lines. In DU 145 cells, treatment with a pharmacologic FGF-receptor inhibitor or a neutralizing anti-FGFR1 antibody mimicked LOX-PP inhibition of serum-stimulated DNA synthesis. FGF-2-stimulated DNA synthesis, ERK1/2, AKT, and FRS2α activation were found all to be inhibited by LOX-PP in DU 145 cells. LOX-PP reduced specific binding of FGF-2 to DU 145 cells, suggesting that LOX-PP targets FGF signaling at the receptor. Interestingly, PC-3 cells did not respond to FGF-2, consistent with previous reports. We conclude that LOX-PP inhibits proliferation of DU 145 cells by interfering with FGFR(s) binding and signaling, and that LOX-PP has other mechanisms of action in PC-3 cells.
登录
查看更多内容
影响因子:
4.2
作者:
Bansal, R;Magge, S;Winkler, S
通讯作者:
Winkler, S
影响因子:
6
作者:
Giri, D;Ozen, M;Ittmann, M
通讯作者:
Ittmann, M
影响因子:
5.8
作者:
Erlich, Shlomit;Tal-Or, Pazit;Pinkas-Kramarski, Ronit
通讯作者:
Pinkas-Kramarski, Ronit
DOI:
10.1089/153685902760173863
发表时间:
2002-06-01
期刊:
HYBRIDOMA AND HYBRIDOMICS
影响因子:
--
作者:
Blanckaert, VD;Venkateswaran, S;Schelling, ME
通讯作者:
Schelling, ME
影响因子:
4.8
作者:
HAMALAINEN, ER;KEMPPAINEN, R;KIVIRIKKO, KI
通讯作者:
KIVIRIKKO, KI